1887
Volume 2006, Issue 1
  • ISSN: 0253-8253
  • E-ISSN: 2227-0426

Abstract

Background: A consensus has emerged that angiotensin-converting-enzyme (ACE) inhibitors and angiotensin-II receptor blockers (ARBs) have specific renoprotective effects. Guidelines specify that these are the drugs of choice for the treatment of hypertension in patients with renal disease. We sought to determine to what extent this consensus is supported by the available evidence.

Loading

Article metrics loading...

/content/journals/10.5339/qmj.2006.1.25
2006-06-01
2019-11-13
Loading full text...

Full text loading...

http://instance.metastore.ingenta.com/content/journals/10.5339/qmj.2006.1.25
Loading
  • Article Type: Abstract
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error